Insider Trading: Alkermes Plc (ALKS.O)

ALKS.O on Nasdaq

31.04USD
20 May 2013
Price Change (% chg)

$-0.65 (-2.05%)
Prev Close
$31.69
Open
$31.59
Day's High
$33.04
Day's Low
$31.00
Volume
2,242,225
Avg. Vol
1,307,106
52-wk High
$33.04
52-wk Low
$14.82

Search Stocks
BIBERSTEIN KATHRYN L Options Exercised: 0
Trade Date: Wednesday, 30 Jan 2013 Price: 23.13
Title: General Counsel Shares Held: 42,665
Type Traded: Direct Net Change in Shares This Filing: 0
» More Insider Trading

Institutional Holders

% Shares Owned: 96.02%
# of Holders: 234
Total Shares Held: 127,872,956
3 Mo. Net Change: 6,698,134
# New Positions: 36
# Closed Positions: 24
# Increased Positions: 117
# Reduced Positions: 87
# Net Buyers: 30

Officers & Directors

Name Age Since Current Position

Richard Pops

 50 2011 Chairman of the Board, Chief Executive Officer

Shane Cooke

 50 2011 President

James Frates

 45 2011 Chief Financial Officer, Senior Vice President

Gordon Pugh

 54 2011 Chief Operating Officer, Senior Vice President, Chief Risk Officer

Kathryn Biberstein

 53 2011 Senior Vice President, Chief Compliance Officer, General Counsel, Secretary

James Botkin

 63 2011 Senior Vice President - Operations

Elliot Ehrich

 53 2011 Senior Vice President - Research and Development, Chief Medical Officer

Michael Landine

 58 2011 Senior Vice President - Corporate Development

Mark Stejbach

 49 2012 Senior Vice President, Chief Commercial Officer

Mark Skaletsky

 2011 Lead Independent Director

Nancy Wysenski

 2013 Director

David Anstice

 64 2011 Independent Director

Floyd Bloom

 75 2011 Independent Director

Robert Breyer

 68 2011 Independent Director

Wendy Dixon

 56 2011 Independent Director

Geraldine Henwood

 2011 Independent Director

Paul Mitchell

 59 2011 Independent Director
Search Stocks